| 发明名称 |
COMPOUND FOR THE TREATMENT OF TUBERCULOSIS |
| 摘要 |
<p>(5R)-3-[4-[1-[(2S)-2,3-dihydroxypropanoyl]-3,6-dihydro-2H-pyridin-4-yl]-3,5- difluoro-phenyl]-5-(isoxazol-3-yloxymethyl)oxazolidin-2-one, or a pharmaceutically- acceptable salt, or an in-vivo-hydrolysable ester thereof, for use in the treatment of Mycobacterium tuberculosis.</p> |
| 申请公布号 |
WO2010106355(A1) |
申请公布日期 |
2010.09.23 |
| 申请号 |
WO2010GB50445 |
申请日期 |
2010.03.16 |
| 申请人 |
ASTRAZENECA AB;ASTRAZENECA UK LIMITED;KAVERI, DAS;MELNICK, DAVID, ALAN;RADHA, SHANDIL |
发明人 |
KAVERI, DAS;MELNICK, DAVID, ALAN;RADHA, SHANDIL |
| 分类号 |
A61K31/4439;A61K45/06;A61P31/06 |
主分类号 |
A61K31/4439 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
